Asset Details
Do you wish to reserve the book?
Structural basis for antibiotic resistance by chloramphenicol acetyltransferase type A in Staphylococcus aureus
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Structural basis for antibiotic resistance by chloramphenicol acetyltransferase type A in Staphylococcus aureus
Do you wish to request the book?
Structural basis for antibiotic resistance by chloramphenicol acetyltransferase type A in Staphylococcus aureus
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Structural basis for antibiotic resistance by chloramphenicol acetyltransferase type A in Staphylococcus aureus
2025
Overview
Methicillin-resistant
Staphylococcus aureus
(MRSA) exemplifies high-level antibiotic resistance in this major human pathogen. Its resistance to chloramphenicol is majorly conferred by enzymatic inactivation via chloramphenicol acetyltransferases (CATs). This modification sterically blocks the antibiotic’s ribosomal binding and thus neutralizes its inhibitory potency. Although CATs have been structurally studied across diverse bacteria species, the structures of
S. aureus
CATs (saCATs) have remained uncharacterized. To address this gap and elucidate species-specific resistance mechanisms, we determined the first high-resolution crystal structure of saCAT1, the prototypical saCAT enzyme. Structural analysis delineates the active site architecture and reveals the molecular basis for substrate recognition of both chloramphenicol and fusidic acid (FA). Further enzymatic assays demonstrated that the
K
m
value against chloramphenicol is 16.9 µM, and the
K
i
value of the inhibitor FA is 83.7 µM, indicating that the inhibitory capacity of FA is relatively limited. These findings provide an essential structural framework for understanding chloramphenicol resistance in
S. aureus
and facilitate the rational design of novel antimicrobial strategies to combat multidrug-resistant pathogens.
Publisher
Nature Publishing Group UK,Nature Publishing Group,Nature Portfolio
Subject
/ Anti-Bacterial Agents - chemistry
/ Anti-Bacterial Agents - pharmacology
/ Bacterial Proteins - chemistry
/ Bacterial Proteins - metabolism
/ Cats
/ Chloramphenicol - metabolism
/ Chloramphenicol - pharmacology
/ Chloramphenicol acetyltransferase
/ Chloramphenicol O-acetyltransferase
/ Chloramphenicol O-Acetyltransferase - chemistry
/ Chloramphenicol O-Acetyltransferase - genetics
/ Chloramphenicol O-Acetyltransferase - metabolism
/ E coli
/ Enzymes
/ Humanities and Social Sciences
/ Humans
/ Methicillin-Resistant Staphylococcus aureus - drug effects
/ Methicillin-Resistant Staphylococcus aureus - enzymology
/ Science
/ Staphylococcus aureus - drug effects
